| Financial Year |
March 31 2023 |
| Monetary Funds |
928,521,530.97 |
| Held-for-trading Financial Assets |
295,168,783.00 |
| Notes Receivable |
83,435,501.19 |
| Accounts Receivable |
310,999,647.09 |
| Advances to Suppliers |
318,114,883.03 |
| Other Receivables |
38,072,857.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
1,728,043.34 |
| Dividend Receivable |
-- |
| Inventories |
830,368,963.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
53,868,178.58 |
| Total Current Assets |
2,885,672,212.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
19,914,153.62 |
| Investment Properties |
27,689,212.06 |
| Fixed Assetes |
598,495,846.40 |
| Under-construction Projects |
30,263,885.50 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
318,079,845.88 |
| R&D expenses |
26,167,625.92 |
| Goodwill |
134,798,597.88 |
| Long-Term Deferred and Prepaid Expenses |
7,521,280.53 |
| Deferred Income Tax Assets |
40,927,839.26 |
| Other Non-Current Assets |
32,469,398.59 |
| Sub-Total of Non-Current Assets |
1,277,192,767.48 |
| Total Assets |
4,162,864,980.09 |
| Short-Term Loans |
160,100,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
13,142,063.28 |
| Accounts Payable |
137,571,752.69 |
| Accounts Received In Advance |
5,838,206.52 |
| Employee Compensation Payable |
37,007,355.60 |
| Taxes Payable |
74,430,910.64 |
| Interest Payable |
167,531.88 |
| Dividend Payable |
8,869,950.19 |
| Other payables |
51,748,517.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
21,958,048.16 |
| Other Current Liabilities |
86,899,497.21 |
| Sub-Total of Current Liabilities |
1,084,680,869.70 |
| Long-term Loans |
48,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
274,200,947.60 |
| Special Payable |
-- |
| Estimatied Liabilities |
6,099,453.06 |
| Deferred Income Tax Liabilities |
6,560,698.78 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
437,716,483.92 |
| Total Liabilities |
1,522,397,353.62 |
| Paid-In Capital(Or Share Stock) |
1,082,198,663.00 |
| Capital Surplus |
422,202,897.06 |
| Surplus Reserve |
15,773,592.85 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
255,521,671.46 |
| Minority Stockholder's Interest |
864,185,689.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,776,281,936.57 |
| Owner's Equity（Stockholder's Equity） |
2,640,467,626.47 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,162,864,980.09 |
